At The Motley Fool, we're not huge fans of Wall Street.
Whatever the reason, we Foolishly believe that Joe and Jane Investor can pick stocks just as well as Nigel and Vivian CFA. That's why we created Motley Fool CAPS, harnessing the small-w wisdom of the capital-F Foolish crowd to pick the winners of tomorrow. Unfortunately, not everyone is pulling an equal amount of weight.
For the most part, the 83,000 investors currently on CAPS are telling us what we already know: PepsiCo
Thanks for playing. No, really!
Not that we don't appreciate the effort. We do. But today, I'm asking you to broaden your horizons a bit. We still have literally hundreds of stocks out there in CAPS-land that lack the 10 opinions necessary to earn them a CAPS "star" rating.
I'd like to introduce you to just three of these hundreds. If you know the companies in question, please take a moment to tell us whether you like them or hate them, and why. It's really as simple as that.
Serving the good people of Clifton, N.J., and nearby areas for the past 80 years, Clifton Savings Bancorp operates 10 offices providing everything you'd expect from a community bank -- passbook savings, checking accounts, mortgages, and I'm guessing free lollipops for the kids. It's not a particularly good bank, with a mere 1.2% return on equity, and a return on assets of 0.3% -- but at least it's cheap at 1.6 times book value. Nearly every Fool who's looked at this stock hates it, including six out of seven All-Stars polled. Care to explain why they're wrong? Here's your chance.
Providing nursing care and rehab services through more than five dozen locations, Ensign Group occupies a growing niche in an aging America. At less than eight times earnings, but projected to grow at 15% per year over the next half-decade, the stock looks positively cheap -- which probably explains why eight out of the nine ratings so far are positive. Come on over to CAPS, and help this stock earn its stars.
Like Ensign, PharMerica works in the health-care field, providing "institutional pharmacy services" to patients in long-term care settings. Unlike Ensign, profitless PharMerica doesn't have any P/E at all. It does have a couple mil in annual free cash flow, however, so there's hope that GAAP profits aren't too far off. Perhaps that's why this stock gets 100% positive feedback on CAPS. (But feel free to spoil the party if you must.)
Help us, Obi-Wan. You're our only hope.
Each of the above stocks currently falls just one vote short of earning its CAPS stars. That gives you the chance to play the hero today. Literally, with just a click of your mouse, you can provide the deciding vote that puts any one of these stocks over the top, and lets everyone else on CAPS know whether it's ready to trounce the market, or trip over its own feet.
Once again, our candidates are:
Give 'em some love, people.
Fool contributor Rich Smith does not own shares of any company named above. You can find him on CAPS, publicly pontificating under the handle TMFDitty, where he's currently ranked No. 645 out of more than 45,000 rated players. The Fool has a disclosure policy.